Your browser doesn't support javascript.
loading
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.
Marjot, Thomas; Eberhardt, Christiane S; Boettler, Tobias; Belli, Luca S; Berenguer, Marina; Buti, Maria; Jalan, Rajiv; Mondelli, Mario U; Moreau, Richard; Shouval, Daniel; Berg, Thomas; Cornberg, Markus.
Afiliação
  • Marjot T; Oxford Liver Unit, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Nuffield Department of Medicine, Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
  • Eberhardt CS; Center for Vaccinology and Neonatal Immunology, Department of Pathology and Immunology, University of Geneva, Switzerland; Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, University of Geneva, Center for Vaccinology, Geneva University Hospital
  • Boettler T; Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Belli LS; Department of Hepatology and Gastroenterology, GOM Niguarda, Milan, Italy.
  • Berenguer M; Liver Transplantation and Hepatology Unit and Ciberehd, IISLaFe and Hospital Universitario y Politécnico La Fe, Valencia, Spain; Department of Medicine, Universitat de València, Valencia, Spain.
  • Buti M; Liver Unit, Hospital Universitario Valle Hebron, Barcelona, and CIBEREHD del Instituto Carlos II, Spain.
  • Jalan R; Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus, London and European Foundation for the Study of Chronic Liver Failure, Barcelona.
  • Mondelli MU; Division of Clinical Immunology and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Moreau R; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain; Service d'Hépatologie, Hôpital Beaujon, APHP, Clichy, France; Centre de Recherche sur l'Inflammation, INSERM and Université de Paris Cité, Paris, France.
  • Shouval D; Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
  • Berg T; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
  • Cornberg M; Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany; German
J Hepatol ; 77(4): 1161-1197, 2022 10.
Article em En | MEDLINE | ID: mdl-35868584
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / COVID-19 / Hepatopatias / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / COVID-19 / Hepatopatias / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido